Table GPS-3. Last year prevalence of drug use among all adults (aged 15 to 64) in nationwide surveys among the general population

Country – geographical area

Year

Ref.

Age range all adults

Sample size all adults

Cannabis (%)

Cocaine (%) (1)

Amphetamines (%) (2)

Ecstasy (%)
(3)

LSD (%)

Belgium

Flemish Community (Brussels excluded)

 

1994

(1)

18-65

2259

1.5

0.2

0.3

0.1

 

French-speaking Community

 

1996-97

(2)

18-49

976

 

 

 

 

 

French-speaking Community

 

1998-99

(3)

18-49

1008

 

 

 

 

 

French-speaking Community

 

2000

(4)

18-49

694

 

 

 

 

 

National

 

2001

(5)

15-64

7347

 

 

 

 

 

Czech Republic

National

 

2002

(1)

18-64

2526

10.9

1.1

2.5

1.0

National

 

2004

(2)

18-64

3526

9.3

0.2

0.7

3.5

0.4

Denmark

National

 

1990

(1)

>=16

2000

5.0

0.2

0.7

 

 

National

 

1994

(2)

 

 

 

 

 

 

 

National

 

2000

(3)

16-64

11825

6.2

0.8

1.3

0.5

0.2

Germany

East Germany

 

1990

(1)

 

 

 

 

 

 

 

Western Germany

 

1990

(2)

 

 

 

 

 

 

 

Old and New Länder

 

1995

(3)

18-59

7833

4.4

0.8

0.7

0.8

 

Old and New Länder

 

1997

(4)

18-59

8019

4.0

0.6

0.4

0.8

 

National

 

2000

(5)

18-59

8139

6.0

0.9

0.6

0.7

0.2

National

 

2003

(6)

18-59

8061

6.9

1.0

0.9

0.8

0.3

Estonia

National

 

1998

(1)

18-64

2317

2.0

 

1.0

 

 

National

 

2003

(2)

15-64

 

4.6

0.6

1.3

1.7

0.3

Greece

Athens

 

1993

(1)

12-64

2103

2.5

0.2

0.1

 

 

National (except Aegean and Ionian Islands)

 

1998

(2)

15-64

3398

4.4

0.5

0.0

0.1

 

National (except Aegean and Ionian Islands)

 

2004

(3)

15-64

4351

1.7

0.1

0.0

0.2

0.1

Spain

National

 

1995

(1)

15-64

8888

7.3

1.9

1.1

1.3

 

National

 

1997

(2)

15-65

12515

7.6

1.7

0.9

0.9

 

National

 

1999

(3)

15-64

12234

7.0

1.6

0.7

0.8

 

National

 

2001

(4)

15-64

14113

9.7

2.6

1.2

1.9

 

National

 

2003

(5)

15-64

12033

11.3

2.7

0.8

1.4

 

France

National

 

1992

(1)

15-64

2099

3.9

0.3

 

 

 

Metropolitan France

 

1995

(2)

18-75

1787

4.7

0.2

0.3

 

 

National

 

1999

(3)

18-69

1742

7.4

0.2

0.1

0.2

0.1

National

 

2000

(4)

15-64

11317

8.4

0.2

0.2

0.2

0.2

Metropolitan France

 

2002

(5)

15-64

1744

9.8

0.3

0.0

0.3

0.1

Ireland

National

 

1998

(1)

18-64

826

 

 

 

 

 

National

 

1998

(2)

18-64

 

9.4

1.3

2.6

2.4

1.4

National

 

2000

(3)

18-64

907

 

 

 

 

 

National

 

2002-03

(4)

15-64

4918

5.0

1.1

0.4

1.1

0.1

Italy

National

 

2001

(1)

15-44

6032

6.2

1.1

0.1

0.2

0.0

National

 

2003

(2)

15-54

11869

7.1

1.2

0.2

0.4

0.2

Cyprus

National

(4)

2003

(1)

15-65

1000

14.1

0.7

0.2

2.5

 

Latvia

National

 

2003

(1)

15-64

4534

3.8

0.2

1.1

0.8

0.5

Lithuania

National

 

2004

(1)

15-64

4207

2.2

0.3

0.3

0.4

0.1

Luxembourg

National

 

1998

(1)

15-64

 

4.0

0.2

 

0.0

 

Hungary

National

 

2001

(1)

18-65

2359

2.4

0.7

0.7

0.8

0.7

National

 

2003

(2)

18-54

 

3.9

0.4

1.0

1.4

0.5

Malta

National

 

2001

(1)

18-64

1755

0.8

0.3

0.0

0.2

0.1

Netherlands

National

 

1997-98

(1)

15-64

17590

5.5

0.7

0.4

0.8

 

National

 

2001

(2)

15-64

14045

6.1

1.1

0.6

1.5

0.0

Austria

National

 

2004

(1)

15-64

3980

7.5

0.9

0.8

0.9

0.2

Poland

National

 

2002

(1)

16-64

 

2.8

0.5

0.7

0.2

0.4

Portugal

National

 

2001

(1)

15-64

14186

3.3

0.3

0.1

0.4

0.1

Slovakia

National

 

2002

(1)

18-64

1405

3.6

0.6

0.2

0.8

 

National

 

2004

(2)

15-64

1315

4.1

0.5

0.3

1.2

 

Finland

National

 

1992

(1)

18-74

3457

1.2

 

 

 

 

National

 

1996

(2)

16-74

3009

1.9

 

 

 

 

National

 

1998

(3)

15-69

2568

2.5

0.2

0.2

0.2

 

National

 

2000

(4)

15-64

1677

2.2

0.2

0.4

0.3

0.2

National

 

2002

(5)

15-64

2377

2.9

0.3

0.5

0.5

0.1

National

 

2004

(6)

15-64

2352

2.9

0.3

0.6

0.5

0.1

Sweden

National

 

1994

(1)

16-64

806

 

 

 

 

 

National

 

1996

(2)

16-64

1136

 

 

 

 

 

National

 

1998

(3)

16-64

1359

0.9

0.1

0.1

0.0

 

National

 

2000

(4)

16-64

1750

0.7

0.0

0.2

0.2

0.0

National

 

2004

(5)

18-64

9514

2.2

 

 

 

 

National

 

2005

(6)

16-64

30538

2.0

 

 

 

 

United Kingdom

England and Wales

 

1994

(1)

16-59

9645

8.4

0.5

2.4

1.0

1.3

England and Wales

 

1996

(2)

16-59

10935

9.5

0.6

3.2

1.7

1.0

England and Wales

 

1998

(3)

16-59

9984

10.3

1.3

3.0

1.5

0.8

England and Wales

 

2000

(4)

16-59

13018

10.5

2.0

2.1

1.8

0.7

England and Wales

 

2001-02

(5)

16-59

20165

10.6

2.0

1.6

2.2

0.3

England and Wales

 

2002-03

(6)

16-59

23586

10.9

2.1

1.6

2.0

0.3

England and Wales

 

2003-04

(7)

16-59

24422

10.8

2.5

1.5

2.0

0.2

England and Wales

 

2004-05

(8)

16-59

28509

9.7

2.0

1.4

1.8

0.2

Northern Ireland

 

2002-03

(9)

15-64

3516

5.4

0.5

0.8

1.6

0.1

Scotland

 

2003

(10)

16-64

3506

7.4

1.4

1.3

1.5

0.1

United Kingdom

 

2004

(11)

35707

10.3

2.3

1.5

1.9

0.2

Bulgaria

National

 

2005

(1)

18-60

1036

1.5

0.3

0.4

0.5

0.2

Romania

National

 

2004

(1)

15-64

 

 

 

 

 

 

Norway

National

 

1999

(1)

15-64

1803

4.5

0.6

1.2

0.7

 

National

 

2004

(2)

15-64

2669

4.6

0.8

1.1

0.5

0.2

Notes:

(1) Cocaine in any form.

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamines and ecstasy.

(3) For Spain: ecstasy and other designer drugs.

(4) Results of this survey should be viewed with caution due to important discrepancies with previous surveys and school surveys results. A new survey with a bigger sample was conducted in 2005.

This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

For methods and definitions see General population surveys of drug use – methods and definitions.

For survey methods see Table GPS-1 part (ii).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0.

Data filter | gpstab04-en.xml